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ABBREVIATIONS 
 
ER Early Repolarization 
ERP Early Repolarization Pattern 
ERV Early Repolarization Variant 
ERS Early Repolarization Syndrome 
BrS Brugada Syndrome 
STEMI ST-segment Elevation Myocardial Infarction 
ECG Electrocardiogram 
IVF Idiopathic Ventricular Fibrillation 
RR Relative Risk 
OR Odds Ratio 
HR Hazard Ratio 
SCA Sudden Cardiac Arrest 
VF Ventricular Fibrillation 
AMI Acute Myocardial Infarction 
ICD Implantable Cardioverter-Defibrillator 
BP Blood Pressure 
SBP Systolic Blood Pressure 
DBP Diastolic Blood Pressure 
BMI Body Mass Index 
c-HDL High Density Lipoprotein Cholesterol 
c-LDL Low Density Lipoprotein Cholesterol 
DM Diabetes Mellitus 
ICD International Classification of Diseases 
SD Standard Deviation  
SPSS Statistical Package for the Social Science  
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ABSTRACT 
 
Title. Association of early repolarization pattern with cardiac mortality in the general 
population. Background. Early repolarization, which is characterized by an elevation of the J-
point on 12-lead electrocardiography, is a common finding that has been considered as benign 
for decades. However, in the last years, it has been related with vulnerability to idiopathic 
ventricular fibrillation and with cardiac mortality in the general population. Recently, 4 
potential ECG predictors that could differentiate the benign from the malignant form of early 
repolarization have been suggested. Any previous study about early repolarization has been 
done in Spain. Aim. To ascertain whether the presence of early repolarization pattern in a 
resting electrocardiogram is associated with a major risk of cardiac death in a Spanish general 
population and to determine whether the presence of potential predictors of malignancy in a 
resting electrocardiogram increases the risk of cardiac mortality in patients with early 
repolarization pattern. Methods. We will analyse the presence of early repolarization and the 
occurrence of cardiac mortality in a retrospective cohort study of 4,279 participants aged 25 to 
74 years in the province of Girona. This cohort has been followed during a mean of 9.8 years. 
Early repolarization will be stratified according to the degree of J-point elevation (≥0.1 mV or 
≥0.2 mV), the morphology of the J-wave (slurring, notching or any of these two), the ST-
segment pattern (ascending or descending) and the localization (inferior leads, lateral leads, or 
both). Association of early repolarization with cardiac death will be assessed by adjusted Cox-
proportional hazards models. Keywords. Early repolarization pattern, malignant criteria of 
early repolarization, J-wave, cardiac mortality.  
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INTRODUCTION  
 
DEFINITION OF EARLY REPOLARIZATION 
Early repolarization is a common electrocardiographic finding that is defined by an elevated 
take-off of ST-segment at the junction between the QRS and ST-segment (J junction) that can 
be associated with notch (a positive deflection inscribed on terminal QRS complex) or slur (a 
smooth transition from the QRS to the ST-segment) on downstroke of R wave (1). 
A                                                     B                                                             C 
 
Figure 1   J-point elevation with slurring (A), notching (B) or neither of these two (C) in the inferior or lateral 
electrocardiogram leads 
 
 
OTHER TERMS USED IN LITERATURE 
Early repolarization (ER), Early Repolarization Pattern (ERP), Early Repolarization Variant (ERV), 
Early Repolarization Syndrome (ERS), J-wave syndrome. 
Considering that a syndrome is a group of symptoms that indicate an abnormal condition, ERS 
is not an appropriate term because ER is usually asymptomatic (2). Moreover, J-wave 
syndromes also include Brugada syndrome (BrS) and acute phase of ST-segment elevation 
myocardial infarction (STEMI), so the most accurate denominations are ER, ERV or ERP (3).  
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EPIDEMIOLOGY OF EARLY REPOLARIZATION  
ER is a common ECG finding in the general population and its prevalence differs depending on 
the study, being estimated at 1 to 13% (4–9). These differences are probably due to the 
different criteria used to define ER. 
It predominates in males (5,7–12), which can be explained by a possible influence of gonad 
steroids (testosterone) (13), as well as a larger epicardial transient outward current (Ito) density 
in men (3).  
ER is more common in young people (4,5,7,9,12) and it has been observed that the ERP tends 
to disappear over 10 years in more than half of patients (12,14,15). Rollin et al. also described 
a decreasing prevalence with advancing age: 35 to 44 years old subjects (16.9%; 95% CI: 13.2 
to 21.1) compared to 45 to 54 years old subjects (12.9%; 95% CI: 9.8 to 16.6) and 55 to 64 
years old subjects (11.6%; 95% CI: 8.6 to 15.1) (9).  
There is a higher prevalence of ER in black people (5,12), although they have been 
underrepresented in studies assessing ER (16). Regarding geographical distribution, it seems 
that ER is particularly prevalent among South-East Asians (13,17).  
The ERP is predominant in physically active individuals (5,6,12,16). The prevalence varies 
according to the level of physical activity, seeing that it ranges from 20% in noncompetitive 
athletes to 90% in high performance athletes (16). 
Finally, as acetylcholine or high parasympathetic tone accentuates the manifestation of ER 
(18), this one is more prevalent among individuals with spinal cord injury at levels of injury that 
can interrupt central sympathetic control of the heart (at the C5-C6 levels) with high vagal tone 
and loss of sympathetic tone (19).  
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ELECTROCARDIOGRAPHIC FEATURES 
Individuals with ER have lower heart rates, possibly because vagal stimulation contributes to 
accelerated repolarization of myocardial fibers (4–6,12). Furthermore, resting sinus 
bradycardia is very often among athletes, who have the highest prevalence of ER. On the other 
hand, it has been observed that idiopathic ventricular fibrillation (IVF) events related to ER 
tend to occur during vagal contexts such as sleeping or after meals (10,18). 
It has also been reported that ER is associated with a shorter and depressed PR interval, 
increased QRS duration, vertical axis, abrupt transition from right to left-oriented complexes in 
the precordial leads, and a higher voltage of QRS, probably as a normal variation due to 
younger age (4). ST-segment has traditionally been characterized by a concave upward 
elevation ending with a symmetrical T wave (1). But Tikkanen et al. reported that ERP could be 
accompanied by an ascending or horizontal/descending ST-segment, and that this was a 
criterion for risk stratification (20). T waves are usually tall, peaked, positive, and most 
remarkably in precordial leads (2) and QTc interval is shorter in patients with ER than in 
controls. Since U waves are frequent in sinus bradycardia, and individuals with ER have lower 
heart rates, U waves are more common in subjects with ER (4). 
In regard to pharmacological responses, it has been found that the infusion of isoproterenol or 
exercise testing reduced the ERP, and beta-blockers such as propranolol restored the 
abnormality, as expected knowing the role of vagal tone in ER (10). On the other hand, 
quinidine, which has been shown to restore transmural electrical homogeneity and abort 
arrhythmic activity in this condition (21), reduced the ERP and eliminated recurrent 
arrhythmias in some subjects (10). Na+ -channel blockers such as ajmaline do not modify ER 
(16), in contrast to the worsening typical of BrS. 
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ELECTROPHYSIOLOGICAL MECHANISMS 
The action potential of the rapid cardiac cells consists in 5 phases. Phase O involves 
depolarization which is caused by the inward Na+-current through the INA channel. Then, in 
phase 1, the early repolarization is initiated due to a transient outward K+-current (Ito). After 
that, inward L-type Ca2+ -current (ICaL) activation counteracts the repolarization K+-current 
inducing the action potential plateau (phase 2). The following outward K+-current (IKr, IKs, IKl) is 
responsible of the late repolarization called phase 3. Finally, in phase 4, INa/Ca channels return 
the membrane back to the resting potential (16). 
To generate the typical ERP is necessary the presence of a prominent Ito in ventricular 
epicardium (responsible of earlier repolarization) but not in endocardium. In this way, the 
transmural voltage gradient developed is manifested in the ECG as a J-point elevation instead 
of a shortening of QT-interval because earlier repolarization occurs only in the epicardium and 
not in the whole wall (22). This is the most accepted electrophysiological mechanism, although 
it is still unclear.  
On top of that, siblings of individuals with ER have an ERP prevalence of 11.6% (sibling 
recurrence risk ratio =1.90; 95% CI: 1.31 to 2.7), so a heritable basis of ER is suggested (7). 
Some mutations that have been described in families with ER are found in the genes KCNJ8, 
CACNA1C, CACNB2b and CACNA2D1 (23). 
 
 
 
 
 
7 
 
DIFFERENTIAL DIAGNOSIS 
ECG pattern of ER should be differentiated from other conditions that involve elevation of ST-
segment (2,4):  
 ER STEMI  ACUTE 
PERICARDITIS 
BrS 
AGE Young people Above 40 Any age Young adults 
CLINICAL 
HISTORY 
Asymptomatic  Typical precordial 
pain 
Precordial pain 
and pericardial 
rub 
Asymptomatic 
 
LABORATORY 
FINDINGS 
Negative Elevation of cardiac 
enzymes  
Mild elevation of 
cardiac enzymes  
Negative 
HEART 
ALTERATIONS 
No structural Structural Structural No structural 
LEADS 
INVOLVED 
Limb/precordial Segmentary pattern Limb/precordial Right precordial 
ST SEGMENT 
APPEARENCE 
Concave to the 
top 
Concave to the top Concave to the 
top  
Convex to the top 
MIRROR IMAGE 
CHANGES 
Only in aVR Present Absent Possible 
PATHOLOGICAL 
Q WAVES 
Negative Positive Negative Negative 
PR INTERVAL Shorter and 
depressed 
Variable Depressed in all 
leads 
Possible 
prolongation 
T WAVES Tall, peaked, 
positive and high  
Tall, peaked in earlier 
stages and become 
negative in late stages 
Positive initially 
and become 
negative in later 
stages  
Negative in right 
precordial leads 
STRESS TEST  Normalizes ST 
elevation 
Without changes Without changes Normalizes ST 
elevation 
FOLLOW-UP ST elevation is 
stable over the 
time 
Dynamic changes of 
the ST segment 
Dynamic changes 
of the ST segment  
ST elevation is 
stable over the 
time 
Table 1   Differential diagnosis of early repolarization pattern 
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ASSOCIATION OF ERP WITH RISK OF CARDIAC MORTALITY 
Case reports 
For decades ERP was considered to be a benign electrocardiographic finding (24–27), but from 
the decade of the 80’s, a growing number of case reports (mostly in Japan) identified 
numerous cases of patients with IVF where the only abnormality found was an ERP (17,28–30). 
From then on, the idea that the ERP was a universally benign normal variant came into 
question.  
Meanwhile, an arrhythmogenic potential mechanism of ER was demonstrated in experimental 
studies. It was found the presence of a transmural electrical heterogeneity, which under 
certain conditions, such as the use of specific drugs and various levels of autonomic tone and 
electrolytes, could be dramatically amplified resulting in malignant arrhythmias (21).  
Case control studies 
A definitive turning point in the perception of ER came in 2008 when Haïssaguerre et al. 
demonstrated a clinical association between ER and sudden cardiac arrest (SCA) in a case-
control study. They considered a new definition of ER based on the presence of J-wave either 
as slurring or notching (J-point elevation without one of these two waves was not included), in 
at least 2 leads other than V1 through V3 and with minimum amplitude of 0.1 mV; Since then, 
the majority of the posterior studies have used the same definition of ERP (6,8,9,13,20). 
Haïssaguerre et al. observed ER in 31% of the cases (206 patients who survived IVF) compared 
with 5% of the controls (412 matched control subjects). After adjustment for age, sex, race and 
level of physical activity, the odds ratio (OR) for the presence of ER in case subjects, as 
compared with control subjects, was 10.9 (95% CI, 6.3 to 18.9). ERP was also associated with 
an increased incidence of recurrent ventricular arrhythmias during follow-up with defibrillator 
monitoring, obtaining a hazard ratio (HR) for recurrence of 2.1 (95% CI, 1.2 to 3.5; P=0.008). 
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Furthermore, in 18 subjects electrocardiography was performed during an arrhythmic period, 
and a significant increase in the J-point amplitude was observed, as compared with baseline. 
On the other hand, the initiating focus of ventricular arrhythmias was concordant with the 
localization of repolarization anomalies in most of the case subjects (10). 
Subsequently, Rosso et al. compared the ECG of 45 patients with IVF with those of 124 age-and 
gender-matched control subjects and with those of 121 young athletes, and found that young 
athletes had ER more often than control subjects but less often than patients with IVF. They 
estimated that only 3.4 of 100,000 young adults develop IVF and that the presence of ER 
increased this risk to only 11 of 100,000, a negligible difference (11). 
Other studies that support the idea that ER is significantly more common among subjects with 
IVF than in healthy control subjects have been published (31–33). 
Population studies 
The prognostic significance of the ERP in the general population is controversial because some 
studies have found that there is no significant association between the ERP and cardiac 
mortality (5,13,34), whereas other studies show that ER increases the risk for arrhythmia 
death, cardiac death or all-cause death (6,8,9,35). 
Klatsky et al. found a prevalence of ER in the general population of 1% and concluded that 
individuals with ER had not any increased risk for death or hospitalization for cardiac causes. 
However, the reason why he did not find any relationship between ER and cardiac death could 
be that they defined ER focusing only on the ST-elevation (without taking into account slurring 
and notching). Subsequent analyses of a sample of ECGs by the investigators showed that 
approximately 1 of 2 controls also had ER, suggesting that the prevalence of ER was 
underestimated in this study (5).   
Another prospective study examined all the ECG records of the 5,976 atomic-bomb survivors 
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and found a follow-up positive rate of ER of 23.9% and an incidence of 715 per 100,000 
person-years. The prevalence reported in other studies is usually lower, and the authors 
suggested that the difference could be explained because the median age of this population 
was younger and because they based their calculation on both prevalent and incident cases 
(13). However, the median ages of the population from various prospective studies have been 
checked and, in fact, the median age of the mentioned study (47±15 years) was not younger 
(for example, the median age of the population from the study of Tikkanen et al. was 44±8 
years (6)). On the other hand, they reported that ERP predicted unexpected death, and as 
radiation dose was not associated with ERP or unexpected death, the results should be 
generalizable. Surprisingly, ERP had a favorable effect on cardiac and all-cause death. To justify 
that finding, the authors proposed the hypothesis that testosterone may modulate cardiac and 
total mortality in ERP cases. Various reports indicate that testosterone may be associated with 
ERP and several studies have reported that low serum testosterone level increases risk of 
cardiovascular and all-cause mortality in men. Thus, elevated serum testosterone level may 
influence the prognosis of patients with ERP by decreasing the risk of cardiac and all-cause 
death (13). 
In 2009 Tikkanen et al. published a study where they assessed the prevalence and prognostic 
significance of ER in a Finnish population of 10,864 middle-aged subjects (mean age, 44±8 
years). The mean follow-up was 30±11 years. The prevalence of ER was 5.8% in this cohort. 
Inferior ER was associated with an increased risk of cardiac mortality [relative risk (RR) 1.28; 
P=0.03] and from arrhythmia (RR 1.43; P=0.03); However, these subjects did not have a 
significantly higher rate of death from any cause (RR 1.10; P=0.15). ER in the lateral leads was 
of borderline significance in predicting cardiac death and all-cause death, but it did not predict 
death from arrhythmia (6). 
Shortly after, another study on ER prevalence and prognosis was conducted in a German 
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population of 1,945 subjects (mean age, 52±10 years) from the MONICA/KORA cohort. The 
mean follow-up was 18.9 years. The results were a prevalence of ER of 13.1% and a statistically 
significant association between ER and cardiac and all-cause mortality, most pronounced in 
those of younger age (8). Similar conclusions were reached by Rollin et al. in a study that 
followed-up 1,161 southwestern French subjects 35 to 64 years old (mean age, 49.8±8.6 years) 
(9). 
Interestingly, in these three studies, the mortality rates of the patient groups with and without 
ER begin to diverge by the age of 50 years. A plausible explanation could be that patients with 
ERP have increased dispersion of repolarization that places them at increased risk for 
arrhythmic death, but only in the presence of additional proarrhythmic triggers, such as 
myocardial ischemia (36). Supporting this data, three recent studies suggest that patients who 
have ERP are at increased risk for developing ischemic ventricular fibrillation (VF) (37–39). 
Meta-Analysis 
In the absence of agreement about the risk of cardiac death, arrhythmia death and all-cause 
death in the general population with ERP, a meta-analysis was conducted summarizing all 
published prospective studies and case- control studies to date (40). 
Of the 9 studies included, 3 studies (6,13,35) reported on arrhythmia death (31,981 subjects, 
1,108 incident cases during 726,741 person-years of follow-up), 6 studies (5,6,8,9,13,34) 
reported on cardiac death (126,583 subjects, 10,010 incident cases during 2,054,674 person-
years of follow-up), and 6 studies (5,6,8,13,34,35) reported on all-cause death (112,443 
subjects, 22,165 incident cases during 2,089,535 person-years of follow-up). 
The ERP was associated with a higher risk of arrhythmia death (RR 1.70; P=0.003) but not 
cardiac death (RR 0.78; P=0.640) or all-cause death (RR 1.06; P=0.570). Furthermore, the ERP 
was associated with a low to intermediate absolute incidence rate of arrhythmia death (70 
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cases per 100,000 person-years of follow-up).  
 
RISK STRATIFICATION OF EARLY REPOLARIZATION PATTERN 
ECG characteristics that could distinguish benign from malignant ER have been suggested: 
- J-wave amplitude: J-point elevation ≥0.2 mV versus J-point elevation ≥0.1 mV has been 
suggested to be of importance in the risk stratification of subjects with ERP. In case-
control studies, it has been found that the magnitude of the J-wave elevation in the 
case group (patients who suffered SCA) tends to be higher than that in the control 
group (10,11,41). Furthermore, another case-control study by Naruse et al. found that 
J-point amplitude ≥0.2 mV was associated with an increased occurrence of VF within 
48 hours after an acute myocardial infarction (AMI) onset (37). In a study by Tikkanen 
et al., it was found that subjects with J-point elevation of at least 0.1 mV in the inferior 
leads had a higher risk of death from cardiac causes (adjusted relative risk, 1.28; 95% 
CI, 1.04 to 1.59; P=0.03) and from arrhythmia (adjusted relative risk, 1.43; 95% CI, 1.06 
to 1.94; P=0.03), but not from all-cause death (adjusted relative risk, 1.10; 95% CI, 0.97 
to 1.26; P=0.15). On the other hand, subjects with J-point elevation of more than 0.2 
mV on inferior leads had an increased risk of death from any cause (adjusted relative 
risk, 1.54; 95% CI, 1.06 to 2.24; P=0.03) and a markedly elevated risk of death from 
cardiac causes (adjusted relative risk, 2.98; 95% CI, 1.85 to 4.92; P<0.001) and from 
arrhythmia (adjusted relative risk, 2.92; 95% CI, 1.45 to 5.89; P=0.01). It is worthy to 
highlight that a J-point elevation ≥0.2 mV seems to be rare in the general population 
(6). However, J-wave elevation amplitude was not found to distinguish benign from 
malignant ER in a study by Rollin et al (9).  A possible explanation for these differences 
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could be that J-wave amplitude varies during the day depending on heart rate and 
neurovegetative tone (18). 
 
- ER localization: Among general population, ERP is usually more frequent in inferior 
leads than in lateral leads, and only a small percentage presents ERP in both lateral 
and inferior leads (6,8,9). In the case-control study by Haïssaguerre et al., most cases 
had the ERP in the inferior or both inferior and lateral leads, 44% and 47% respectively 
(10). In other case-control studies, ERP in the inferior leads resulted more frequent in 
the SCA group than in the control group (37,41). Tikkanen et al. found that inferior ERP 
increased arrhythmic and cardiac death, but not all-cause mortality. Conversely, ER in 
the lateral leads was of borderline significance in predicting cardiac death and all-
cause death, but it did not predict death from arrhythmia (6). Sinner et al. reported 
that ERP in inferior localization was associated with a higher risk of cardiac and all-
cause death than ERP in any localization (8). Discordant conclusions were reached by 
Rollin et al., who found that ERP localization did not distinguish benign from malignant 
forms of ERP (9). A recently meta-analysis by Wu et al. has concluded that ERP in 
inferior leads or in both inferior and lateral leads increases the risk of arrhythmic 
death, and that ERP in lateral leads has not a statistically significant association (40).  
 
- Morphology of J-wave: In patients with ERP, slurring has been found to be more 
frequent than notching (8,20). In case-control studies, notching has been reported to 
be more prevalent in malignant variants of ER (IVF cases) than in benign cases (11,32).  
In patients with AMI, notching configuration has been also found to be more frequent 
in patients who develop VF than in individuals who do not suffer this complication 
(37,38). Moreover, in a prospective study, notching ERP (but not slurring ERP) has 
been associated with increased all-cause and cardiovascular mortality (9), and a meta-
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analysis has reported that a notching configuration (but not a slurring configuration) 
has an increased risk for arrhythmia death (40). In contrast, Tikkanen et al. could not 
conclude definite differences between prognostic significance of notching and slurring 
in ERP (20).  
A part from slurring and notching, another pattern will be considered in our study: J-
point elevation without slurring neither notching. This pattern was assessed by Klatsky 
et al. and they did not find association with cardiac mortality (5). 
 
- St-segment pattern: Tikkanent et al. reported that rapidly ascending ST-segment was 
the typical pattern found in athletes with ER, and that in the general population, the 
horizontal ST-segment pattern was more frequent. They also found that the group 
with horizontal/descending ST-segment showed a subtle male dominance, was older 
and had a higher prevalence of ECG signs of coronary artery disease. In contrast, 
subjects with rapidly ascending/upsloping ST-segment were younger, more often men, 
had lower body mass index, lower heart rate, lower blood pressure and higher 
prevalence of ECG left ventricular hypertrophy. In view of these findings, it was 
suggested that the upsloping ST-segment pattern was a reflection of athlete ECG 
changes (20). 
In subjects with ER, horizontal/descending ST-segment has been associated with a 
higher risk of sudden arrhythmic death and cardiac death, but rapidly 
ascending/upsloping ST-segment has not been associated with adverse outcome 
(9,20,43). Furthermore, some case-control studies have reported that 
horizontal/descending ST-segment helped to distinguish patients with SCA from 
controls matched by gender and age (41,44). An inverse correlation between the slope 
of the ST-segment and the mortality risk during long-term follow-up has been reported 
(42). On the other hand, in patients who suffer from vasospastic angina, those who 
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have ER and horizontal ST-segment have a higher risk for arrhythmic death compared 
with those who have ER and ascending ST-segment (45).  
In two recent studies, notching and horizontal ST-segment have been reported to be 
predictive of VF in AMI (37,38) and interestingly, Rollin et al. found a strong association 
between these two patterns (9).  
In view of the above results, it is clear that there is still controversy regarding the factors that 
can contribute to risk stratification of ER and that there is a need of identifying the ER patterns 
that distinguish benign from malignant forms (36,46). Even so, it seems that a J-point elevation 
≥0.2 mV, an inferior or inferolateral localization, a notching configuration and a 
horizontal/descending ST-segment could characterize malignant ER. 
 
CURRENT PROBLEM WITH EARLY REPOLARIZATION 
ER is a common ECG finding in the general population, but there is a lack of knowledge about 
its prognostic significance. Three possible tendencies have been suggested. First, some authors 
still defend that ER is a benign finding which is lost with age (14,15). Second, other authors 
claim that patients with ER appear to be at higher risk of IVF (10,11,31–33). As this is a rare 
disease which affects young adults, even if the presence of ER increases this probability, only 
11 of 100,000 young adults with ER develop IVF, which represents an almost insignificant risk 
magnitude (11). Finally, ER has been associated with an increased mortality risk in the general 
population (6,8,9), but only in the presence of additional proarrhythmic triggers, such as 
myocardial ischemia (36). In this situation, ER increases mortality rates by the age of 50 years. 
On the other hand, assuming that a malignant form of ER exists, criteria of risk stratification in 
patients with ER are not still accorded. 
This is the basis why conclusive recommendations regarding treatment and follow-up of 
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subjects with ER remain to be totally clarified. Based on present knowledge, patients with 
asymptomatic ER are better left alone and the only reasonable recommendation to be made 
now is to reduce their long-term risk of ischemic VF by treating their modifiable risk factors for 
coronary artery disease (36,46). In symptomatic ER patients, implantable cardioverter-
defibrillators (ICD) should be considered as a primary option for secondary prevention of fatal 
arrhythmias (47). Drug therapies that seem to be effective are isoproterenol for the 
management of electrical storm during the acute phase and quinidine for the management of 
recurrent VF during the chronic phase (48). Catheter ablation of the ectopy initiating the VF 
could be another potential modality for the management of VF patients with ER (10). In 
asymptomatic ER subjects with a strong family history of sudden cardiac death, drug treatment 
with quinidine or/and prophylactic implantation of an ICD should be considered (47). 
Due to all these reasons, we want to carry forward a cohort study to analyse the association 
between the ERP and its different subgroups with cardiac mortality. Moreover, it will be 
performed in a sample of Girona, in the northeast of Spain, where ER has never been studied 
and where the incidence of cardiac mortality is known to be lower than in the rest of Europe or 
in the United States, where the majority of the studies about ER have been developed. 
 
 
 
 
 
 
17 
 
HYPOTHESES  
 
The presence of early repolarization pattern in a resting electrocardiogram is not associated 
with a major risk of cardiac mortality in general population, except in certain subgroups of 
patients. 
To identify which patients with early repolarization have an increased risk of cardiac death, 
four potential predictors are suggested:  
1) Early repolarization distribution: early repolarization pattern in inferior or both inferior 
and lateral leads are associated with an increased risk of cardiac death compared with 
early repolarization pattern in lateral leads.  
2) J-wave morphology: the presence of notching is associated with an increased risk of 
cardiac death compared with the presence of slurring or with the absence of these two 
in patients with early repolarization. 
3) J-wave amplitude: the presence of a J-wave amplitude ≥ 0.2 mV is associated with an 
increased risk of cardiac death compared with the presence of a J-wave amplitude ≥0.1 
mV in patients with early repolarization. 
4) ST-segment morphology: the presence of a horizontal or descending ST-segment is 
associated with an increased risk of cardiac death compared with the presence of an 
ascending ST-segment in patients with early repolarization. 
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OBJECTIVES 
 
Main objective 
To ascertain whether the presence of early repolarization pattern in a resting 
electrocardiogram is associated with a major risk of cardiac death in a Spanish general 
population of individuals aged 25-74 years. 
Secondary objective 
To determine whether the presence of potential predictors of malignancy in a resting 
electrocardiogram increases the risk of cardiac mortality in patients with early repolarization 
pattern. 
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METHODS  
 
DESIGN 
Retrospective population-based cohort study in which we will analyse if the presence of early 
repolarization pattern in a resting ECG increases the risk of cardiac mortality in a general 
population of Girona. 
 
PARTICIPANTS 
The subjects of this study are participants of the REGICOR study. It consists of two cohorts 
aged 25 to 74 years old that were recruited in 1995 and 2000 in the province of Girona, in the 
northeast of Spain, with the original purpose of studying cardiovascular risk factors. All these 
subjects have been followed since then. 
The reference population of the province of Girona was 600,000 inhabitants. The 25 to 74 age 
group included approximately 50% women and 50% men. About half of the population lived in 
towns of more than 10,000 inhabitants. These data were obtained from previous population 
censuses. 
1,748 participants were selected in 1995, and 3,058 in 2000. The selection consisted in a 
stratified random sampling in two stages. In the first one, some populations of Girona were 
chosen at random: 33 in 1995 and 17 in 2000. It was taken into account the fact that half of 
the sample came from urban zones (>10,000 inhabitants) and the rest from rural regions 
(between 500 and 10,000 inhabitants). And the second stage was the random recruitment of 
the same quantity of participants, men and women, stratified in 5 age-groups (25-34, 35-44, 
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45-54, 55-64 and 65-74 years). 
The final sample consisted of 4,279 patients because some individuals did not participate due 
to missing ECG or other data (276 subjects), and of the remaining 4,530 participants, 251 were 
excluded because the ECG was unreadable. 
A letter informing about the aims of the study was sent to all the selected people. The tests to 
be performed were also described and participants were asked to attend the health 
examination in a fasting state of at least 14 hours; a telephone number was provided for 
inquiries. The participants were contacted by telephone one week before the examination to 
confirm their attendance. Examinations were performed by a physician, two nurses, and two 
auxiliaries who went to all the participating towns in teams composed of the physician (always 
the same), a nurse and an auxiliary.  
 
INCLUSION AND EXCLUSION CRITERIA 
Inclusion criteria 
- People aged 25 to 74 years old from the two cohorts of 1995 and 2000 of the REGICOR 
study. 
Exclusion criteria 
- Unreadable ECGs 
 
SAMPLE SIZE 
Assuming an incidence rate of cardiac death in the province of Girona of 211.3/100 000 
inhabitants/year (49), we expect to find some 90 cardiac deaths in a mean follow-up of 9.8 
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years in the cohort. It represents a proportion of events of 2.1% during the follow-up. We 
assume that the event rate in non-exposed participants to early repolarization will be 2.1% at 
9.8 years. 
There are 4,279 participants. Accepting an alpha risk of 0.05 in a one-sided test, this sample 
size and number of expected cardiac deaths provide a statistical power of 83% for a hazard 
ratio of 2, for a dichotomous factor (early repolarization) that is 10% prevalent (4–9), to 
recognize as statistically significant the difference between the two groups. 
 
MEASUREMENTS 
Identification data 
At baseline, sociodemographic data from each participant were collected by a questionnaire 
(name, date of birth, gender, home address and others). 
Electrocardiogram 
A standard resting 12-lead electrocardiogram was obtained for each participant with a digital 
electrocardiograph CARDDIOLINE Delta 60 Plus. ECG of each participant was interpreted 
blindly (without clinical information of the participant and with an anonymous identifier) by 
the same senior cardiologist and classified under the Minnesota ECG Code (50).  
Early repolarization pattern 
Between 2009 and 2011, a pilot test was performed to train the investigators in recognising 
the ER pattern in order to increase the internal validity of the study. All the ECG were analysed 
manually using paper prints. Two investigators were blinded to clinical data and follow-up 
status and they jointly assessed the presence of ERP, the localization of ERP and the J-wave 
morphology in the ECGs. A third blinded trained cardiologist reviewed a sample of these ECGs 
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to check that they were being correctly analysed.  
The criteria for detection of ER were the following: an elevated take-off of ST-segment at the 
junction between the QRS and ST-segment (J junction) that could be associated with notch (a 
positive deflection inscribed on terminal QRS complex) or slur (a smooth transition from the 
QRS to the ST-segment) on downstroke of R wave. The pattern had to be present in ≥ 2 
adjacent leads in the inferior leads (II, III, and aVF), lateral leads (I, aVL, and V4 to V6), or both. 
Furthermore, amplitude of J-point of at least 0.1 mV above the isoelectric line was required. 
The anterior precordial leads (V1 to V3) were not interpreted to avoid confusion with ECG 
patterns of BrS or right ventricular dysplasia.  
In this study, we have used a different definition of ERP in comparison to the one described by 
Haïssaguerre et al. (10). We have included not only the patients who presented slurring or 
notching, but also individuals with J-point elevation followed by a concave upward ST-
elevation without these two features. We believed that this criterion was necessary to define 
ERP because it has been the one classically used in daily clinical practice.  
The results of this pilot test are shown in table 2 and table 3, in the chapter of results. 
During the bibliography research, it was seen that 4 possible malignant criteria of ERP were 
suggested: J-wave morphology, ERP localization, J-point amplitude and ST-segment pattern. 
So, when the ECGs are further revised, these malignancy variables will be also collected.   
These malignancy criteria are: 
- J-point elevation: it will be distinguished if the J-point amplitude is ≥0.1 mV or ≥0.2 
mV. In case that J-point elevation is not the same in the different leads, we will choose 
the highest measure. 
- ST-segment pattern: it will be classified as rapidly ascending or horizontal/descending 
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ST-segment. ST-segment patterns will be coded following the criteria of Tikkanen et al: 
the rapidly ascending ST-segment was considered as > 0.1 mV elevation of ST-segment 
within 100 ms after the J-point or a persistently elevated ST-segment of >0.1 mV 
throughout the ST-segment. Horizontal/descending type was defined as ≤0.1 mV 
elevation of the ST-segment within 100 ms after the J-point (20). 
- Localization of ERP: it will be catalogued as inferior leads (II, III, and aVF), lateral leads 
(I, aVL, and V4 to V6), or both. 
- J-wave configuration:  ER will be divided into notching (a positive deflection inscribed 
on terminal QRS complex), slurring (a smooth transition from the QRS to the ST-
segment) or neither (only J-point elevation).  
Heart rate 
Heart rate will be measured manually using a standard rule and it will be described as a 
continuous variable. 
ECG signs of left ventricular hypertrophy  
They were assessed and catalogued using the Minnesota ECG Code (50).  
The criteria for the diagnosis of left ventricular hypertrophy corresponded to Minnesota code 
3.1. 
ECG signs of coronary artery disease 
They were assessed and catalogued using the Minnesota ECG Code (50). 
The criteria for the diagnosis of coronary artery disease corresponded to Minnesota codes 1.1 
to 1.2 and 4.1. 
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Blood pressure 
Blood pressure (BP) was measured with a mercury sphygmomanometer in 1995 and an 
automatic aneroid in 2000, calibrated periodically. The operator followed a certification 
process in the standardised measurement technique at central laboratory and all 
determinations were always made by the same person.  
It was measured in the right arm. Only in case of impossibility or anatomical abnormalities, it 
was taken in the left arm, writing in the questionnaire the reason for this change. BP was 
recorded in the box for the arm that was taken. A cuff adapted to upper arm perimeter (young, 
adult, obese) was selected for each participant. The chamber of the cuff should encircle at 
least 80% of the arm. 
Measurements were performed after a five minutes rest with arms resting at heart level. 
Patients should avoid smoking or drinking caffeine for 30 minutes prior to the determination of 
blood pressure. Two measurements were taken: the interval between the first and second was 
at least 5 minutes. The value used was the arithmetic mean of both determinations. If there 
was a difference of more than 5 mmHg between the first and the second taking (either in the 
systolic BP or diastolic BP), there was a third measurement, separated from the second by 
more than 3 minutes. 
Hypertension 
Personal history of hypertension and its treatment was recorded by an adapted questionnaire. 
Hypertension will be considered when: 
- A personal history of hypertension is reported. 
- A treatment for hypertension is followed. 
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- Systolic blood pressure is ≥140 mmHg or diastolic blood pressure is ≥90 mmHg in 
patients neither diagnosed nor treated. 
- Systolic blood pressure is ≥130 mmHg or diastolic blood pressure is ≥85 mmHg in 
diabetic participants. 
Anthropometric measurements 
A precision scale of easy calibration was used for weight measurement. Participants wore 
underwear.  
Height was measured in centimeters without shoes. Measurements shall be rounded up to 
whole centimeters. 
Body mass index (BMI) will be determined as weight divided by squared height (kg/m2). BMI 
will be considered as a continuous variable. 
Laboratory findings (glycaemia, cholesterol, triglycerides) 
Total cholesterol, high density lipoprotein cholesterol (c-HDL), triglycerides, low density 
lipoprotein cholesterol (c-LDL) and basal glycaemia were analysed. 
Extractions were made after a 14 hour fast without venous compression (or less than 60 
seconds duration when strictly necessary) using a syringe with a holder and vacuum tubes with 
separating gel. Samples were centrifuged between 30 and 60 minutes after extraction and the 
serum samples immediately frozen at -120ºC in liquid nitrogen, and transported within seven 
days to a refrigerator set at -80ºC for definitive conservation. Analyses were performed at an 
interval of three to four months after extraction in groups of 600 samples. 
Total cholesterol and triglycerides concentrations were determined enzymatically (Roche 
Diagnostica, Basel, Switzerland). c-HDL was measured as cholesterol after precipitation of 
apoprotein B containing lipoproteins with phosphotungstic-Mg++ (Boehringher Mannheim, 
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Mannheim, Germany).  
Analyses were performed in an Cobas Mira Plus (Roche Diagnostica, Basel Switzerland). 
External quality assessment was performed with External Quality Assessment-WHO Lipid 
Program (World Health Organisation, Prague, Czech Republic) and Monitrol-Quality Control 
Program (Baxter Diagnostics, Dudingen, Switzerland). Interassays coefficients of variation were 
2.5%, 4.5%, and 3.2% for total cholesterol, HDL cholesterol, and triglycerides, respectively. c-
LDL was calculated by the Friedewald equation. 
Diabetes 
Personal history of diabetes mellitus (DM) and its treatment was recorded by an adapted 
questionnaire. 
Diabetes will be considered when: 
- A personal history of DM is reported. 
- A treatment for DM is followed. 
- Basal glycaemia is ≥126 mg/dl (7mmol/L) in patients neither diagnosed nor treated. 
Dyslipidaemia 
Personal history of dyslipidaemia and its treatment was recorded by an adapted questionnaire. 
Dyslipidaemia will be considered when: 
- A personal history of dyslipidaemia is reported. 
- A treatment for dyslipidaemia is followed. 
- Total cholesterol concentration is ≥240 mg/dl (6.2 mmol/L) in patients neither 
diagnosed nor treated. 
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- c-LDL concentration is ≥ 160 mg/dl (4.1 mmol/L) in patients neither diagnosed nor 
treated. 
- c-HDL concentration is ≤ 40 mg/dl (1.0 mmol/L) in patients neither diagnosed nor 
treated. 
- Triglycerides concentration is ≥150 mg/dl (1.7 mmol/L) in patients neither diagnosed 
nor treated. 
Smoking assessment 
The questionnaire applied in the study consisted of questions regarding current and past 
cigarette consumption including daily amount. 
Smokers will be considered when cigarette consumption is ≥1 cigarette/day or in case of 
former smokers <1 year. 
Follow-up and events of interest 
The follow-up of the cohort was done between 2006 and 2009 including a structured 
telephone survey to all the participants to determine if they had had any cardiovascular 
diseases since their inclusion in the study.  Database of participants was crossed with the 
Mortality Registry of Catalonia and the Mortality Rate of the Ministry of Health. Death cause 
was evaluated using the 10th revision of the International Classification of Diseases (ICD-10) 
and death of cardiac causes was assumed for ICD-10 codes I00-I99. In case of cardiac death, 
diagnoses from autopsies were collected when performed and medical records of the hospitals 
in the region were reviewed. 
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ETHICAL ASPECTS 
Participants were duly informed and gave signed consent at the time of inclusion, authorising 
maintenance of a secure computerised database with their personal data for further 
investigations. They also authorised the investigators to draw a fasting blood specimen, to 
retain frozen samples of serum and plasma, and to be contacted for follow-up interviews. The 
test results were sent to the participants. Furthermore, to respect and guarantee the 
confidentiality of the patients, the investigators do not have access to individual confidential 
data and the data will be analysed anonymously.  
The REGICOR study was approved by the IMAS (Institut Municipal d’Assistència Sanitària) 
Ethics Committee. National and international guidelines for human studies (code of ethics, 
declaration of Helsinki of 1964) and Spanish legal regulations on confidentiality of personal 
data (Ley Orgánica 15/1999 de 13 de Diciembre de Protección de Datos de Carácter Personal 
[LOPD]) has and will be followed during all this study. 
 
STATISTICS 
Continuous variables will be presented as means ±SD as appropriate and categorical variables 
will be presented as percentages in each group.  
Continuous variables are age, BMI and heart rate. Categorical variables are ER, cardiac 
mortality, J-wave morphology, J-point elevation, ER localization, ST-segment pattern, sex, 
dyslipidaemia, arterial hypertension, diabetes, smoking habit, ECG signs of left ventricular 
hypertrophy and ECG signs of coronary artery disease.  
Cardiac mortality incidence will be compared according to presence or absence of ER using chi-
square test or Fisher’s exact test in case of small expected numbers. The hazard ratios and 95% 
29 
 
confidence intervals for cardiac death will be calculated using the Cox-proportional hazards 
models. The adjustments in these models will be done for age, sex, dyslipidaemia, arterial 
hypertension, diabetes, BMI, smoking habit, heart rate, ECG signs of left ventricular 
hypertrophy and ECG signs of coronary artery disease.  
All statistical analyses will be carried out using the Statistical Package for the Social Science 
(SPSS), version 14.0, and all tests will be considered statistically significant at a p value ≤0.05. 
 
RESULTS 
 
Table 2: Prevalence of early repolarization in the pilot test, according to J-wave morphology 
 Any morphology Slurring Notching J-point elevation without 
slurring nor notching 
Subjects 
(n) 
Percentage 
(95% CI) 
Subjects 
(n) 
Percentage 
(95% CI) 
Subjects 
(n) 
Percentage 
(95% CI) 
Subjects 
(n) 
Percentage 
(95% CI) 
ER 2166 50.6 
(49.1-52.1) 
2157 50.4 
(48.9-51.9) 
25 0.6 
(0.4-0.8) 
27 0.6 
(0.4-0.8) 
 
We have found a prevalence of ER of 50.6% in our cohort, remarkably higher in comparison to 
other published studies (4–9). This is due in large part to a high prevalence of slurring (50.4%). 
In contrast, the prevalence of notching and J-point have not differed too much compared with 
other previous studies (8,20).  
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Table 3: Prevalence of early repolarization in the pilot test, according to ER localization 
 Any localization Inferior leads Lateral leads Inferior and lateral 
leads 
Subjects 
(n) 
Percentage 
(95% CI) 
Subjects 
(n) 
Percentage 
(95% CI) 
Subjects 
(n) 
Percentage 
(95% CI) 
Subjects 
(n) 
Percentage 
(95% CI) 
ER 2166 50.6 
(49.1-52.1) 
862 
 
20.1 
(18.9-21.3) 
884 20.7 
(19.5-21.9) 
420 9.8 
(8.9-10.7) 
 
We have found a similar prevalence of ER in inferior and lateral leads, being 20.1% and 20.7% 
respectively. Prevalence in inferolateral leads has been of 9.8%. In comparison to other studies 
(6,8,9), the prevalence of ERP in lateral leads has been higher. 
Models of tables in which the final results of the study will be presented, are proposed below: 
Table 4:   Study Population Characteristics  
Variable Total sample Men Women P-value 
Subjects     
Age (years)     
Hypertension (%)     
Diabetes mellitus (%)     
Dyslipidaemia (%)     
Smoking habit (%)     
BMI (kg/m2)     
Heart rate (beats/min)     
ECG signs of left ventricular 
hypertrophy (%) 
    
ECG signs of coronary 
artery disease (%) 
    
ERP (%)     
Mortality incidence (%)     
 
BMI: body mass index; ERP: early repolarization pattern 
 
Data are expressed as n (%) or mean ± standard deviation 
31 
 
Table 5:   Adjusted Hazard Ratios of death, according to the different subgroups of ER 
(compared to the group without ER) 
Model HR (95% CI) 
Global ER  
J-point elevation 
  ≥0.1 mV 
  ≥0.2 mV 
 
ER localization 
  Inferior leads 
  Lateral leads 
  Both inferior and lateral leads 
 
J-wave morphology 
  Slurring 
  Notching 
  J-point elevation only 
 
ST-segment pattern 
  Ascending 
  Descending 
 
 
Variables that were included in the multivariate analyses were age, sex, dyslipidaemia, arterial 
hypertension, diabetes, body mass index, smoking habit, heart rate, ECG signs of left ventricular 
hypertrophy and ECG signs of coronary artery disease. 
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STRENGHTS AND LIMITATIONS 
 
Our study is characterized as representative of a North East region of the peninsula due to a 
high rate of participation (about 70%). Another major strength of this study is the use of the 
REGICOR cohort being characterized by detailed risk factor and ECG information and long 
follow-up. The cohort design provides a high strength of evidence, and the systematic and 
blinded fashion of the ECG analysis can be considered a strong point. 
Among notable limitations of this study, the low rate of incidence of cardiac death observed in 
Spain, and especially in the zone of Girona, will complicate the extrapolation of our results in 
other populations (49). Moreover, inherent to our study design, we will not be able to note the 
influence of ERP outside the age range of 25-74 years and more studies will be required to 
clear up the impact of ERP in younger individuals.  
Another weakness of this study is that the assessment of death by death certificates 
sometimes cannot specify the accurate cause of cardiac death, particularly the occurrence of 
sudden cardiac death. It would be reasonable to assume that if early repolarization increases 
the risk of cardiac death, it also increases the risk of sudden cardiac death because 50% of 
cardiac deaths are due to sudden death (51). However, further studies will be needed to mark 
out the real underlying cause of death to encourage the hypothesis of a presumably 
arrhythmic death due to ERP. 
Finally, as it is a purely epidemiologic investigation, any physiopathologic links between ERP 
and increase of cardiovascular mortality will be suggested. 
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CRONOGRAM  
 
Activity 1990 1995 
and 
2000 
2006-
2009 
2009-
2011 
June  
2013 
July  
2013 
August  
2013 
Sept.  
2013 
Oct.  
2013 
Nov. 
2013 
Dec. 
2013 
January 
2014 
February  
2014 
March 
2014 
April 
2014 
May 
2014 
 
June 
2014 
Ethical committee 
(REGICOR study) 
                 
Data collection (REGICOR 
study) 
                 
Telephone call for follow-
up (REGICOR study) 
                 
Death certificates 
obtaining (REGICOR 
study) 
                 
Autopsies and medical 
records review (REGICOR 
study) 
                 
Coordination meeting 1                    
Pilot test 
 
                 
Coordination meeting 2                   
Bibliography research                   
Protocol elaboration                   
Coordination meeting 3                    
ERP assessment 
 
                 
Results analysis 
 
                 
Coordination meeting 4                   
Final article elaboration                  
Publication and 
dissemination of data 
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Activity Investigators 
Data collection (REGICOR study) REGICOR group 
Telephone call for follow-up (REGICOR study) REGICOR group 
Death certificates obtaining (REGICOR study) REGICOR group 
Autopsies and medical records review (REGICOR study) REGICOR group 
Pilot test Raquel Bosch / Anna Llorens 
Bibliography research Anna Llorens 
Protocol elaboration Anna Llorens 
ERP assessment (ECG) Ramon Brugada / Raquel Bosch / Anna Llorens  
Results analysis IDIAP group 
Final article elaboration Ramon Brugada / Raquel Bosch / Anna Llorens 
Publication and dissemination of data Ramon Brugada / Raquel Bosch / Anna Llorens 
 
 
BUDGET 
 
Activity  Costs 
Statistical analysis 1,050 € 
Translation costs 500 €  
Publication costs 2,000 € 
National journey for diffusion of the data 1,000 € 
International journey for diffusion of the data 2,000 € 
Total  6,550 € 
 
As our research group do not include any statistician, we have to subcontract this service. It 
will cost approximately 35 €/h and 30 hours will be needed. A translation service is also 
necessary in order to publish the final article in English. A member of our research group 
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should participate in a national and an international congress to diffuse the results of this 
study.  
 
RESEARCH GROUP 
 
Our research group includes multidisciplinary experts such as epidemiologists, cardiologists, 
general practitioners and medical students. So the capacity of the research group to develop 
this scientific study is remarkably.  
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